Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Filings indexed 371 across all filing types
Latest filing 2021-01-21 Legal Proceedings Report
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
소송등의제기ㆍ신청(경영권분쟁소송)(주주명부열람및등사가처분)
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a legal proceeding ('소송 등의 제기ㆍ신청') specifically involving a management dispute ('경영권 분쟁 소송') and a request for inspection of the shareholder register ('주주명부 열람 및 등사 가처분'). This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2021-01-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register (stock transfer suspension) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend or share issuance, it falls under the general regulatory filing category.
2020-12-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders (Lee Tae-hun and others) due to a capital increase (rights offering). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a specific individual (Lee Tae-hun, CEO) in the company 'Jeonjin Bio-Pharm'. This type of filing is a standard regulatory requirement for insiders (directors/major shareholders) to disclose their transactions and holdings, which falls under the 'Director's Dealing' category.
2020-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions or changes in ownership. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2020-12-09 Korean
증권발행결과(자율공시)(주주배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '증권 발행결과' (Securities Issuance Result) regarding a paid-in capital increase (rights offering) for Jeonjin BioPharm. It details the actual number of shares issued, the amount raised, and the payment completion date. This falls under the category of capital structure changes and share issuance announcements, which is best classified as 'SHA' (Share Issue/Capital Change).
2020-12-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.